Overview

Study of an Approved Drug in Patients With Asthma (0476-289)(COMPLETED)

Status:
Completed
Trial end date:
2004-06-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety of an approved drug on asthma symptoms in patients with chronic asthma which is also active during the allergy season.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Montelukast